Equities researchers at Deutsche Bank began coverage on shares of Henry Schein (NASDAQ:HSIC) in a report released on Friday. The firm set a “buy” rating and a $79.00 price target on the stock. Deutsche Bank’s target price suggests a potential upside of 16.35% from the company’s previous close.

A number of other equities research analysts also recently issued reports on the stock. Credit Suisse Group reissued a “hold” rating and issued a $87.50 price target on shares of Henry Schein in a research note on Tuesday, August 29th. Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. Craig Hallum raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, November 13th. Finally, Morgan Stanley started coverage on shares of Henry Schein in a research note on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $87.79.

Henry Schein (NASDAQ HSIC) opened at $67.90 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. Henry Schein has a 52 week low of $65.28 and a 52 week high of $93.50. The company has a market cap of $10,657.18, a PE ratio of 19.05, a price-to-earnings-growth ratio of 1.91 and a beta of 0.99.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, November 6th. The company reported $0.87 EPS for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.03). The firm had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. Henry Schein’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period last year, the firm earned $0.84 earnings per share. equities analysts predict that Henry Schein will post 3.6 EPS for the current fiscal year.

Henry Schein declared that its Board of Directors has authorized a share repurchase plan on Monday, September 18th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the company to buy up to 6.3% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

In related news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $70.76, for a total value of $410,124.96. Following the completion of the transaction, the director now owns 48,172 shares in the company, valued at $3,408,650.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.19% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. YorkBridge Wealth Partners LLC grew its holdings in shares of Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after purchasing an additional 28 shares in the last quarter. Sun Life Financial INC grew its holdings in shares of Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after purchasing an additional 573 shares in the last quarter. FTB Advisors Inc. grew its holdings in shares of Henry Schein by 100.0% in the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after purchasing an additional 742 shares in the last quarter. Trust Co. of Vermont grew its holdings in shares of Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after purchasing an additional 616 shares in the last quarter. Finally, Lee Financial Co grew its holdings in shares of Henry Schein by 100.0% in the third quarter. Lee Financial Co now owns 1,756 shares of the company’s stock valued at $144,000 after purchasing an additional 878 shares in the last quarter. Hedge funds and other institutional investors own 91.75% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Henry Schein (HSIC) Coverage Initiated at Deutsche Bank” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/henry-schein-hsic-coverage-initiated-at-deutsche-bank/1755607.html.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.